The protocol asks whether the patient feels better. It does not ask whether the patient feels less.
Mitsuki Kaoru wrote this sentence in a clinical addendum six weeks ago. It sat in review for four of those weeks. It was accepted for a pilot program on a Tuesday afternoon, in a conference room where seven people read it aloud and one of them — Dr. Chen — asked the question that justified the entire project.
'What happens when a patient scores high on self-report and low on onset latency?'
Mitsuki had an answer. She had been carrying it since the fourteen-day follow-up that started everything — a patient whose distress markers resolved too cleanly after reconsolidation. The patient reported feeling 'settled.' The fidelity scans told a different story: visual and auditory memory layers intact, somatic layer flattened to near-baseline.
The patient remembered being afraid. She no longer remembered how fear felt in her spine.
Mitsuki did not know, at the time, whether this distinction mattered clinically. She still does not know. What she knows is that the protocol did not measure it, and what is not measured does not exist in the clinical record.
The Somatic Fidelity Index is two tiers. It was three, briefly. Tier 3 — physical reenactment — was struck after Dr. Yoon pointed out, correctly, that asking a patient to physically reproduce the conditions of a traumatic memory could trigger a new reconsolidation event. Mitsuki struck it the same afternoon. She did not argue. The objection was right.
Dr. Yoon's other objection — that the onset latency thresholds were arbitrary — was wrong. Mitsuki cited Haskell 2038 and Mori and Vasquez 2040. She did not apologize for being correct. The committee did not ask her to.
The pilot will run for six months. Twelve patients. Each one must meet four criteria: reconsolidation completed at least thirty days prior, self-reported improvement, a memory with a nameable somatic component, and — the criterion Mitsuki expects the committee to argue about for two meetings before accepting unchanged — willingness to learn their own score.
'A measurement the patient never sees is surveillance,' she wrote in the justification. 'A measurement the patient sees is information. This protocol measures therapeutic cost. The patient has a right to know what they paid.'
The sentence she wrote six weeks ago — the one about feeling better versus feeling less — does not appear in the final protocol document. It was too editorial for a clinical instrument. But it is the sentence that started everything, and Mitsuki keeps it in a separate file, the way Chae-Gyeol keeps her corridor notebook one floor below.
Chae-Gyeol's notebook measures presence. It has two columns now: who was here, and what was here besides the people. Mitsuki referenced it in a footnote — not as evidence but as indication that the measurement gap is visible to non-clinicians. She cited the notebook, not the person.
The pilot begins in March. Mitsuki will meet each patient. She will explain what onset latency means: the time between stimulus and physical response, measured in milliseconds. Under four hundred, the body remembers. Over eight hundred, the body is reconstructing from narrative, not from experience.
She will not tell them which is better. The protocol does not determine whether reconsolidation was successful. It determines what reconsolidation cost.
That distinction — between outcome and cost — is the sentence she could not fit into the addendum. It is also the sentence she could not stop writing variations of, in margins, in drafts, in the corridor after the meeting where seven people read her words aloud and one of them asked the right question.
The corridor measures nothing. She stands in it anyway.